Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NUCLEIC ACID MOLECULES INSERTED EXPRESSION REGULATION SEQUENCES, EXPRESSION VECTOR COMPRISING NUCLEIC ACID MOLECLUES AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/209079
Kind Code:
A1
Abstract:
A nucleic acid molecule including at least one expression control sequence having an Internal Ribosomal Entry Site (IRES) sequence, at least one coding region, and optionally multiple adenosines or thymidines upstream of the at least one expression control sequence is disclosed as an expression system. Besides, a recombinant expression vector including the nucleic acid molecule and pharmaceutical or medicinal use of the nucleic acid molecule are disclosed.

Inventors:
NAM JAE HWAN (KR)
PARK HYO JUNG (KR)
KO HAE LI (KR)
KIM HUN (KR)
KWAK HAE WON (KR)
Application Number:
PCT/KR2019/005099
Publication Date:
October 31, 2019
Filing Date:
April 26, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CATHOLIC UNIV KOREA IND ACADEMIC COOPERATION FOUNDATION (KR)
International Classes:
C12N15/67; A61K39/12; A61K48/00
Domestic Patent References:
WO2003031630A12003-04-17
WO2004018630A22004-03-04
Foreign References:
KR20190061114A2019-06-05
Other References:
CHARBONNEAU, J. ET AL.: "The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes", RNA, vol. 18, no. 3, 27 January 2012 (2012-01-27), pages 519 - 529, XP055649141
LO, H. L. ET AL.: "Development of an RNA Expression Platform Controlled by Viral Internal Ribosome Entry Sites", JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 29, no. 1, 28 November 2018 (2018-11-28) - 28 January 2019 (2019-01-28), pages 127 - 140, XP055649150
Attorney, Agent or Firm:
SA, Kwang Young (KR)
Download PDF: